Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pathologic Complete Response × Colonoscopy × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 49 Colonic Neoplasms 20 Adenoma 14 Colonic Polyps 12 Polyps 6 Colorectal Neoplasms, Hereditary Nonpolyposis 5 Adenomatous Polyps 5 Pain 4 Neoplasms 4 Disease 4 Rectal Neoplasms 3 Colitis, Ulcerative 2 Anus Neoplasms 2 Adenomatous Polyposis Coli 2 Turcot syndrome 1 Recurrence 1 Personal Satisfaction 1 Patient Satisfaction 1 Pathologic Complete Response 1 Lymphoma, Mantle-Cell 1 Irritable Bowel Syndrome 1 Inflammatory Bowel Diseases 1 Hyperplasia 1 HIV Infections 1 Diverticulitis, Colonic 1 Diverticulitis 1 Digestive System Diseases 1 Crohn Disease 1 Colorectal Adenoma 1 Colon Cancer Screening 1

Interventions

Trastuzumab 6 Carboplatin 6 Docetaxel 5 Paclitaxel 4 Oxaliplatin 4 Fluorouracil 4 Cytarabine 4 Cyclophosphamide 4 Azacitidine 4 pertuzumab 3 pembrolizumab 3 Radiotherapy 3 Epirubicin 3 Cisplatin 3 Chemoradiotherapy 3 Capecitabine 3 venetoclax 2 sargramostim 2 olaparib 2 durvalumab 2 cc-486 2 Surgical Procedures, Operative 2 Standard of Care 2 Pemetrexed 2 Observation 2 Monatide (IMS 3015) 2 Metformin 2 Leucovorin 2 Irinotecan 2 Immunotherapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon ⚡